You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting i death. Granulocyte colony-stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Conformational Stabilization of the HIV-1 Env Trimer
SBC: AVATAR MEDICAL, LLC Topic: NIAIDDESCRIPTION provided by applicant Avatar is developing HIV vaccine immunogens based on dityrosine DT crosslinking of soluble native Env gp trimers Several of the most potent broadly neutralizing Abs andquot bnAbsandquot preferentially bind native Env trimers and a trimeric immunogen thus would both present a wide range of key neutralizing epitopes and simultaneously focus immune responses away fro ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
SBC: THERMAL GRADIENT, INC. Topic: NIAIDDESCRIPTION provided by applicant Rapid Portable HIV Detection and Monitoring System The long term objectives of this project are Develop a prototype of a rapid portable instrument for detecting and measuring the amount of Human Immunodeficiency Viruses HIVandapos s in samples of patient blood particularly in low resource settings Carry out a pilot study to establish the effectivene ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
SBC: THERMAL GRADIENT, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Rapid, Portable HIV Detection and Monitoring System The long term objectives of this project are: 1. Develop a prototype of a rapid portable instrument for detecting and measuring the amount of Human Immunodeficiency Viruses (HIV's) in samples of patient blood, particularly in low resource settings. 2. Carry out a pilot study to establish the effectiveness ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Organocatalysis for the treatment of sickle cell disease
SBC: NANOMETICS LLC Topic: NHLBIDESCRIPTION (provided by applicant): Sickle cell disease (SCD) is a global health issue that affects ~100,000 Americans and over 13 million people worldwide. The complexity of the disease dictates that a multimodal approach to treatment will likely be needed. SCD is manifested physiologically during acute events of sickle crisis as the distorted red blood cells impede blood flow, causing physiolog ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Approach-specific, multi-GPU, multi-tool, high-realism neurosurgery simulation
SBC: KITWARE INC Topic: 100DESCRIPTION provided by applicant Approach specific Multi GPU Multi tool High realism Neurosurgery Simulation Surgical treatment of neurological diseases is complicated and requires advanced training However compressed internship schedules in hospitals creates a challenge to young surgeons to master techniques needed for such complex procedures Surgical simulators are powerful tools to p ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Social Ecological Model for Community and Home-based Nutrition Education
SBC: Transcendent International, LLC Topic: NICHDDESCRIPTION (provided by applicant): Striking changes in dietary patterns and decreases in physical activity have driven the prevalence of obesity among American children to epidemic proportions; low-income and ethnic minority families are especially vulnerable to the socio-economic barriers that influence obesity, with Latino populations being the most severely affected. The proposed interactive, ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Automating Directly Observed Therapy as a Platform Technology
SBC: AICURE, LLC Topic: NCATSDESCRIPTION (provided by applicant): Introduction: Ai Cure Technologies LLC was established in 2009 to develop automated medication adherence monitoring solutions using computer vision technology. This SBIR Phase II will allow Ai Cure Technologies to testthe accuracy and validity of its flagship product, AiView . The SBIR Phase I demonstrated that the AiView platform was technically feasible and ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia
SBC: Sharklet Technologies Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Ventilator-associated pneumonia (VAP) is the most costly and second most common hospital-acquired infection (HAI), accounting for over 86% of hospital-acquired pneumonia (HAP). Some 300,000 HAP patients are treated annually in the U.S., at an estimated annual hospital cost of more than 1.5 billion. The current paradigm for preventing VAP has been to implement ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health